| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000228386.2 |
Cytarabine |
Breast invasive carcinoma |
0.045948552 |
Resistant |
| ENSG00000228386.2 |
Cytarabine |
Esophageal cancer |
0.019643019 |
Resistant |
| ENSG00000228386.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.008534847 |
Resistant |
